Corvus Pharmaceuticals, Inc. - COM (CRVS)

Historical Portfolio Holders from Q1 2016 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
27.6M
Holdings value Q2 2024
$50.2M
Value change Q2 2024
+$17.7M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
46
Number of buys Q2 2024
19
Number of sells Q2 2024
-17
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 27.6M $50.2M +$17.7M $1.82 46
2024 Q1 17.9M $31.9M -$2.28M $1.78 47
2023 Q4 19.2M $33.8M +$90.9K $1.76 46
2023 Q3 19.2M $28M -$1.23M $1.46 52
2023 Q2 19.5M $44.6M +$708K $2.29 53
2023 Q1 20.8M $18.9M -$184K $0.91 36
2022 Q4 21.4M $18.2M -$606K $0.85 38
2022 Q3 22.1M $18.1M -$3.46M $0.82 39
2022 Q2 25.6M $25.3M -$3.28M $0.99 41
2022 Q1 27.4M $44.9M -$1.2M $1.64 53
2021 Q4 27.7M $66.7M -$7.83M $2.41 60
2021 Q3 28.2M $136M +$22.9M $4.84 58
2021 Q2 23.7M $63.2M +$8.57M $2.67 44
2021 Q1 20.4M $62.8M +$12.1M $3.08 45
2020 Q4 16.3M $58.1M -$3.25M $3.56 35
2020 Q3 17.2M $69M -$11.7M $4.01 34
2020 Q2 20.4M $55.6M -$392K $2.72 34
2020 Q1 20.7M $43.6M -$3.31M $2.11 36
2019 Q4 20.8M $113M -$10.4M $5.44 35
2019 Q3 22.9M $68.9M -$4.06M $3.01 34
2019 Q2 24.3M $91M -$1.5M $3.74 43
2019 Q1 24.8M $99.5M -$1M $4.02 56
2018 Q4 25.1M $92.2M -$1.84M $3.67 60
2018 Q3 25.5M $219M -$3.32M $8.58 60
2018 Q2 25.9M $284M +$6.77M $10.98 56
2018 Q1 25.3M $288M +$90.6M $11.53 54
2017 Q4 17.4M $180M -$3.16M $10.36 53
2017 Q3 17.5M $280M +$933K $15.94 52
2017 Q2 17.5M $212M -$2.85M $12.10 47
2017 Q1 17.3M $360M +$9.74M $20.77 52
2016 Q4 17.5M $250M +$17.4M $14.30 53
2016 Q3 16.3M $268M -$17M $16.45 44
2016 Q2 17.3M $237M +$14.5M $14.26 45
2016 Q1 16.4M $228M +$226M $14.50 32